EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Triple-Negative Breast Cancer Treatment Advancements: A Review of Evolving Strategies

Guozheng Liu, Yanwen Zhang, Yong Huang

European Journal of Cancer Care · 08.04.2024 · 2024 · 1-12

DOI: 10.1155/2024/8299502 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer Care, erschienen am 08.04.2024. Verfasst von Guozheng Liu und 2 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Scientific and Technological Innovation Major Base of Guangxi.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Women around the world are most frequently afflicted with breast cancer, and it is one of the most frequent causes of cancer death in females. Breast cancer is usually classified according to biomarker status, triple‐negative breast cancer (TNBC) represents a distinct subtype characterized by immunohistochemical findings that denote negativity for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (Her-2) on cancer tissue. It is more common in younger women than in other subtypes. As an invasive breast cancer subtype with a unique drug-resistant phenotype and metastatic burden, it has limited treatment options, and patients have a poor prognosis with high rates of local, distant recurrence and mortality, and there is still a lack of standardized treatment protocols for TNBC. In this review, we delve into the current treatment strategies for TNBC and explore the potential for new approaches and targets in the future. This trial is registered with NCT03997123.

Förderung

  • National Natural Science Foundation of China
  • Scientific and Technological Innovation Major Base of Guangxi

Zitieren

APA

Liu, G., Zhang, Y., & Huang, Y. (2024). Triple-Negative Breast Cancer Treatment Advancements: A Review of Evolving Strategies. European Journal of Cancer Care, 2024, 1-12. https://doi.org/10.1155/2024/8299502

Vancouver

Liu G, Zhang Y, Huang Y. Triple-Negative Breast Cancer Treatment Advancements: A Review of Evolving Strategies. European Journal of Cancer Care. 2024;2024:1-12. doi:10.1155/2024/8299502

BibTeX
@article{Liu2024,
  author = {Liu, Guozheng and Zhang, Yanwen and Huang, Yong},
  title = {Triple-Negative Breast Cancer Treatment Advancements: A Review of Evolving Strategies},
  journal = {European Journal of Cancer Care},
  year = {2024},
  volume = {2024},
  pages = {1--12},
  doi = {10.1155/2024/8299502}
}
Kostenlos starten →